List Drug Pricing Agreements and Annexes
drug_money_agreementsThe 2025-26 drug-pricing agreements in the Medicare Drug Money Register, optionally filtered by company (a substring of a company as the White House, the annexes or the reviewed table name it). Returns the White House fact sheets by date and subject, each with the companies it announced an agreement with or listed, as named, and its quoted lines (a sheet is cited by date and subject; the agreements' texts are not published, and nothing beyond the published texts is read into them); each company's announcement date and list membership; Proclamation 11020's Annex II (company-specific Commerce agreements with their dates) and Annex III (companies) exactly as printed; the proclamation's ad valorem duty rates and the Commerce and USTR notices, as printed; and CMS's payment models: GLOBE's estimates in the proposed and final rules set like for like, GUARD's proposed estimate, and GENEROUS, each with CMS's own estimate and the reasons CMS states, quoted. A White House or CMS share or estimate is that body's own, quoted, and is never set against a figure computed from CMS's files. Each figure is named in its record's own words: "gross drug cost" (CMS), CMS's negotiated prices ("negotiated prices, which the statute refers to as maximum fair prices"), "announced an agreement" (the White House), "ad valorem duty rate" (the proclamation) and CMS's "estimated savings". The blocks (Part D gross drug cost by company, negotiated prices and the negotiated drugs' claims, the 2025-26 agreements, tariffs and CMS's payment models, Part B drug spending, and skin substitutes as totals only) are never added together. Every answer carries the register's question note: these records show Medicare's gross drug costs as CMS reports them, CMS's negotiated prices and estimates, and the government's announcements and proclamations; they do not show rebates paid, what any company agreed to beyond the published texts, or why any price or agreement was set. Every answer also carries the side-by-side caption, the as-of date, each file's date, the source page on morvs.ai and the data's licence. Institutions only: no prescriber, physician, official, signer or member of Congress is named; labeler strings that read as a person's name are withheld and appear only as counts. No party label is given.
Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| company | No | Optional case-insensitive company name substring as the White House, the annexes or the reviewed table print it, for example Pfizer; at most 80 characters. |